Service d'Hématologie et d'Oncologie Médicale, Hôpital du Point G, Bamako, Mali.
Oncology. 2012;83(5):257-63. doi: 10.1159/000341541. Epub 2012 Sep 4.
Few studies have been conducted on breast cancer in Sub-Saharan Africa and their results have been suspected to be impaired by artefacts. This prospective study was designed to determine tumor and patient characteristics in Mali with control of each methodological step. These data are necessary to define breast cancer treatment guidelines in this country.
Clinical and tumor characteristics and known risk factors were obtained in a consecutive series of 114 patients. Each technical step for the determination of tumor characteristics [histology, TNM, grade, estrogen (ER) and progesterone receptors (PR), HER2, and Ki67] was controlled.
Patients had a mean age of 46 years. Most tumors were invasive ductal carcinomas (94%), T3-T4 (90%) with positive nodes (91%), grade III (78%), and ER (61%) and PR (72%) negative. HER2 was overexpressed in 18% of cases. The triple-negative subgroup represented 46%, displaying a particularly aggressive pattern (90% grade III; 88% Ki67 >20%).
This study demonstrates the high incidence of aggressive triple-negative tumors in Mali. Apart from a higher prevalence of premenopausal women, no significant difference in risk factors was observed between triple-negative tumors and other tumors. The hormonal therapy systematically prescribed therefore needs to be revised in light of this study.
在撒哈拉以南非洲地区,针对乳腺癌的研究较少,且其研究结果疑似受到人为因素的影响。本前瞻性研究旨在确定马里的肿瘤和患者特征,并对每个方法步骤进行控制。这些数据对于在该国确定乳腺癌治疗指南是必要的。
连续纳入 114 例患者,获取其临床和肿瘤特征及已知的危险因素。对肿瘤特征(组织学、TNM、分级、雌激素受体 [ER] 和孕激素受体 [PR]、HER2 和 Ki67)的每个技术步骤进行控制。
患者的平均年龄为 46 岁。大多数肿瘤为浸润性导管癌(94%)、T3-T4(90%)伴阳性淋巴结(91%)、分级为 III 级(78%)、ER(61%)和 PR(72%)阴性。HER2 过表达见于 18%的病例。三阴性亚组占 46%,表现出特别侵袭性的模式(90%为 III 级;88%Ki67>20%)。
本研究表明,在马里,侵袭性三阴性肿瘤的发病率较高。除了绝经前妇女的患病率较高外,三阴性肿瘤与其他肿瘤之间未观察到明显的危险因素差异。因此,应根据本研究修订激素治疗方案。